These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2330704)

  • 21. [Comparison of calcium oxalate values as indicators of risk for calcium oxalate calcinosis and the degree of urine saturation in patients with calcium urolithiasis and in healthy patients].
    Głuszek J; Boruczkowska A; Kosicka T; Raszeja-Wanic B
    Pol Tyg Lek; 1989 Feb; 44(9):220-2. PubMed ID: 2813183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenesis of urolithiasis: relation of urinary fibrinolytic activity to nondialyzable urinary solids.
    Charlton CA
    Surg Forum; 1966; 17():503-5. PubMed ID: 4224146
    [No Abstract]   [Full Text] [Related]  

  • 23. [The role of dynamic observation in the prevention of recurrences of stone formation].
    Dzeranov NK; Darenkov AF; Konstantinova OV; Beshliev DA; Borisik VI; Golovanov SA; Drozhzheva VV
    Urol Nefrol (Mosk); 1998; (2):12-4. PubMed ID: 9577694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Local factors compared with systemic factors in the formation of bladder uric acid stones.
    Li WM; Chou YH; Li CC; Liu CC; Huang SP; Wu WJ; Huang CH
    Urol Int; 2009; 82(1):48-52. PubMed ID: 19172097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary glycosaminoglycans are selectively included into calcium oxalate crystals precipitated from whole human urine.
    Suzuki K; Mayne K; Doyle IR; Ryall RL
    Scanning Microsc; 1994; 8(3):523-30. PubMed ID: 7747154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of purines in urinary calculi by high-performance liquid chromatography.
    Safranow K; Machoy Z; Ciechanowski K
    Anal Biochem; 2000 Nov; 286(2):224-30. PubMed ID: 11067744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical studies of the recurrence of urolithiasis (4). Crystal formation in urine and stone recurrence].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1988 Sep; 34(9):1543-7. PubMed ID: 3213790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [New aspects in the etiopathogenesis of urolithiasis].
    Glawtschew P
    Med Welt; 1972 Nov; 23(46):1703-5. PubMed ID: 4636882
    [No Abstract]   [Full Text] [Related]  

  • 29. [Analytical evaluation of urinary calculi mineral composition].
    Machoy P
    Ann Acad Med Stetin; 1995; 41():259-71. PubMed ID: 8615550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The role of agregatometry in diagnosis of urolithiasis].
    Kadyrov ZA; Istratov VG; Suleĭmanov SI; Ramishvili VSh
    Urologiia; 2007; (1):36-40. PubMed ID: 17471996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Etiology and pathogenesis of urolithiasis].
    Kmiecik J; Kucharska E; Sułowicz W; Ochmański W
    Przegl Lek; 1997; 54(3):173-9. PubMed ID: 9297194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Detection of metabolic disorders as a cause of urolithiasis in clinical practice].
    Kocvara R; Louzenský G; Ptácek V
    Cas Lek Cesk; 1989 Mar; 128(10):295-8. PubMed ID: 2720728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Urine surface tension in patients with urolithiasis treated with pharmalite].
    Ivanova M; Georgiev G
    Biofizika; 2002; 47(3):568-9. PubMed ID: 12068618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Urinary urease activity in urolithiasis patients].
    Merkusheva NV; Iushina LV; Makhonina IA
    Urol Nefrol (Mosk); 1997; (4):13-5. PubMed ID: 9381611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Age of onset of urolithiasis: relation to clinical and metabolic risk factors].
    Lancina Martín JA; Novás Castro S; Rodríguez-Rivera García J; Ruibal Moldes M; Blanco Díez A; Fernández Rosado E; Barbagelata López A; González Martín M
    Arch Esp Urol; 2004 Mar; 57(2):119-25. PubMed ID: 15074780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of risk index according to Tiselius in patients with calcium urinary stones].
    Głuszek J; Raszeja-Wanic B; Boruczkowska A; Musialik D
    Pol Tyg Lek; 1989 Feb; 44(9):223-5. PubMed ID: 2813184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Usefulness of determining beta-2-microglobulin in serum and urine in patients with metabolically active kidney calculi and healthy individuals].
    Pupek-Musialik D
    Pol Tyg Lek; 1993 May 17-31; 48(20-22):464-6. PubMed ID: 8170811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Juvenile urolithiasis (the importance of urine collection in its pathogenesis)].
    Vendl L
    Cesk Pediatr; 1986 Apr; 41(4):218-21. PubMed ID: 3719805
    [No Abstract]   [Full Text] [Related]  

  • 39. [Epidemiological study on urolithiasis in Mie Prefecture. 1. Present status in 1985].
    Kawamura J; Yamasaki Y; Tochigi H; Tajima K; Yanagawa M; Hori N; Kato M; Kinoshita N; Arima K; Yamamoto I
    Hinyokika Kiyo; 1986 Sep; 32(9):1225-30. PubMed ID: 3812142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The role of cholesterol and damaged blood-cell membrane in the development of urinary calculi].
    Leskovar P
    MMW Munch Med Wochenschr; 1977 Dec; 119(48):1561-2. PubMed ID: 414099
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.